Clinical Trial

Testing a Multilevel, Culturally Appropriate Lifestyle Intervention For Hispanic Patients With Metabolic Dysfunction-associated Steatotic Liver Disease

Enrolling by Invitation
View on ClinicalTrials.gov →
Summary
The purpose of this study is to understand if a behavioral lifestyle intervention called the Healthy Liver/Hígado Sano program can help Hispanic/Latino patients with metabolic dysfunction associated steatotic liver disease (MASLD), also known as non-alcoholic fatty liver disease (NAFLD), lose weight and improve their liver health
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-09-21; most recent amendment 2026-02-27.
Status change: Not Yet Recruiting → Enrolling by Invitation 2026-02-26
Trial Details
NCT Number NCT07199491
Lead Sponsor The University of Texas Health Science Center, Houston
Collaborators: National Institute on Minority Health and Health Disparities (NIMHD)
Conditions Metabolic-dysfunction Associated Liver Disease (MASLD)
Enrollment 64 participants
Start Date 2026-01-29
Primary Completion 2027-10-31 (estimated)
Study Completion 2027-10-31 (estimated)
Updated on ClinicalTrials.gov 2026-03-03